BioNTech plans to further investigate the drug’s potential in combination with mRNA vaccines, targeted therapies and ...

Reactogenicity is comparable for simultaneous and sequential administration of mRNA COVID-19 and influenza vaccines.

COVID-19 vaccination coverage has progressed unevenly throughout the world. Moreover, 1.01 and 1.43 doses for each person are ...

Tiny lab-grown models of human immune systems are helping researchers understand why cancer patients struggle to fight ...